KPV

Research

KPV (Lysine-Proline-Valine)

Aliases
alpha-MSH fragment
Administration
Subcutaneous injection (research), Oral (research), Topical (research)

How it works

  1. Inhibits NF-κB nuclear translocation, reducing pro-inflammatory gene expression

    It blocks a key internal switch (NF-κB) that turns on inflammation genes inside cells.

  2. Suppresses TNF-α, IL-1β, and IL-6 production

    It lowers production of several major inflammatory signaling molecules.

  3. Reduces neutrophil infiltration in inflamed tissue

    It reduces how many immune cells rush into already-inflamed tissue, calming the response down.

Result

Reduced inflammation at the source, making it a common addition to recovery-focused peptide combinations. People often notice less swelling, redness, and discomfort in inflamed areas, particularly the gut or skin.